Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?

Authors

Christine A. Fargeas
Aurelio Lorico, Touro University NevadaFollow
Denis Corbeil, Touro University NevadaFollow

Roles

Author

Document Type

Article

Publication Date

1-1-2021

Publication Title

Frontiers in Oncology

DOI

10.3389/fonc.2021.712358

Recommended Citation

Fargeas, C. A., Lorico, A., & Corbeil, D. (2021). Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.712358